|•||Q1 2014 Press Release:||May 1, 2014 at 7:00 a.m. ET|
|•||Q1 2014 Conference Call:||May 1, 2014 at 8:30 a.m. ET|
|•||Domestic Dial-In Number:||877-407-8037|
|•||International Dial-In Number:||201-689-8037|
|•||Conference ID #||13580001|
Pfizer (PFE) has agreed to acquire Medivation (MDVN) for $14 billion, fueling speculation of a future deal with Incyte (INCY).
Barclays increased its price target to $100 on Incyte (INCY) stock this morning.
The company's share price despite reporting better-than-expected earnings and revenue and